First Trust Direct Indexing’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-72,828
| Closed | -$8.67M | – | 620 |
|
|
2024
Q3 | $8.67M | Buy |
72,828
+1,198
| +2% | +$143K | 0.47% | 29 |
|
|
2024
Q2 | $10.2M | Buy |
71,630
+2,782
| +4% | +$397K | 0.63% | 19 |
|
|
2024
Q1 | $8.84M | Buy |
68,848
+61
| +0.1% | +$7.83K | 0.66% | 19 |
|
|
2023
Q4 | $7.12M | Buy |
68,787
+7,647
| +13% | +$791K | 0.64% | 22 |
|
|
2023
Q3 | $5.56M | Buy |
61,140
+462
| +0.8% | +$42K | 0.64% | 21 |
|
|
2023
Q2 | $4.91M | Sell |
60,678
-528
| -0.9% | -$42.7K | 0.55% | 25 |
|
|
2023
Q1 | $4.87M | Buy |
61,206
+1,886
| +3% | +$150K | 0.58% | 23 |
|
|
2022
Q4 | $4.01M | Buy |
59,320
+3,080
| +5% | +$208K | 0.53% | 31 |
|
|
2022
Q3 | $2.8M | Buy |
56,240
+798
| +1% | +$39.8K | 0.41% | 42 |
|
|
2022
Q2 | $3.09M | Buy |
55,442
+1,150
| +2% | +$64.1K | 0.43% | 39 |
|
|
2022
Q1 | $3.02M | Buy |
54,292
+3,252
| +6% | +$181K | 0.37% | 45 |
|
|
2021
Q4 | $2.86M | Buy |
51,040
+1,098
| +2% | +$61.5K | 0.37% | 47 |
|
|
2021
Q3 | $2.4M | Buy |
49,942
+1,096
| +2% | +$52.6K | 0.34% | 50 |
|
|
2021
Q2 | $2.05M | Buy |
48,846
+33,932
| +228% | +$1.42M | 0.31% | 62 |
|
|
2021
Q1 | $503K | Buy |
14,914
+2,366
| +19% | +$79.8K | 0.13% | 212 |
|
|
2020
Q4 | $438K | Buy |
+12,548
| New | +$438K | 0.12% | 213 |
|